Yale Podnos Oncology Institute, Inc. (TOI) insider trading activity

Yale Podnos is Chief Medical Officer of Oncology Institute, Inc.. Currently has a direct ownership of 237,930 shares of TOI, which is worth approximately $944,582. The most recent transaction as insider was on Nov 17, 2025, when has been sold 2,086 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 238K

1.53% 3M change

226.07% 12M change

Total Value Held $944,582

Yale Podnos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 17 2025	BUY Grant, award, or other acquisition	-	2,086 Added 0.87%	237,930 Common Stock
Nov 12 2025	BUY Grant, award, or other acquisition	-	1,508 Added 0.64%	235,844 Common Stock
May 21 2025	SELL Sale (or disposition) back to the issuer	$4,808 $2.67 p/Share	1,801 Reduced 0.76%	234,336 Common Stock
Mar 31 2025	BUY Grant, award, or other acquisition	-	157,088 Added 39.95%	236,137 Common Stock
Mar 26 2025	BUY Open market or private purchase	$9,418 $1.04 p/Share	9,056 Added 10.28%	79,049 Common Stock
Mar 19 2025	SELL Sale (or disposition) back to the issuer	$2,647 $0.89 p/Share	2,975 Reduced 4.08%	69,993 Common Stock
Nov 20 2024	SELL Sale (or disposition) back to the issuer	$420 $0.14 p/Share	3,002 Reduced 3.95%	72,968 Common Stock

Nov 12 2024	SELL Other acquisition or disposition	-	28,398 Reduced 27.21%	75,970 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	-	17,530 Added 14.38%	104,368 Common Stock
Nov 21 2023	SELL Sale (or disposition) back to the issuer	$3,350 $2.19 p/Share	1,530 Reduced 1.73%	86,838 Common Stock
Nov 14 2023	SELL Sale (or disposition) back to the issuer	$5,014 $2.39 p/Share	2,098 Reduced 2.32%	88,368 Common Stock
Mar 17 2023	BUY Grant, award, or other acquisition	-	33,219 Added 26.86%	90,466 Common Stock
Nov 17 2022	BUY Grant, award, or other acquisition	-	14,164 Added 19.83%	57,247 Common Stock
Nov 15 2022	SELL Sale (or disposition) back to the issuer	$403 $2.03 p/Share	199 Reduced 0.46%	43,083 Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	-	14,884 Added 25.59%	43,282 Common Stock
Nov 12 2021	BUY Grant, award, or other acquisition	-	28,398 Added 62.5%	17,039 Common Stock

Yale Podnos

Chief Medical Officer

Cerritos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Value

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI

Account